Patent application number | Description | Published |
20120328259 | MULTIMEDIA CONTENT PREVIEW RENDERING IN A CLOUD CONTENT MANAGEMENT SYSTEM - Systems and methods for providing content previews of files, including video files, stored in an online content management system with collaboration environment are disclosed. Permission to view a preview of a file is determined based upon access permissions associated with the file and/or workspace in which the file is stored and the access level of the requesting user. The system can also provide a progress indicator indicating the approximate time remaining to process the file for previewing based upon averages of times for processing previous files having similar attributes. In one aspect, embodiments of the present disclosure include a method, which may be implemented on a system, for downsampling a video file to decrease the processing time for providing a preview. | 12-27-2012 |
20130097115 | AUTOMATIC AND SEMI-AUTOMATIC TAGGING FEATURES OF WORK ITEMS IN A SHARED WORKSPACE FOR METADATA TRACKING IN A CLOUD-BASED CONTENT MANAGEMENT SYSTEM WITH SELECTIVE OR OPTIONAL USER CONTRIBUTION - Systems and methods for supporting metadata for work items stored in a web-based content management system with collaboration environment are disclosed. Users uploading work items to a folder are not required to provide metadata for the work items. Collaborators of the folder can provide metadata to work items within the folder. | 04-18-2013 |
20130111326 | ENHANCED MULTIMEDIA CONTENT PREVIEW RENDERING IN A CLOUD CONTENT MANAGEMENT SYSTEM | 05-02-2013 |
20130262210 | CLOUD SERVICE OR STORAGE USE PROMOTION VIA PARTNERSHIP DRIVEN AUTOMATIC ACCOUNT UPGRADES - System and method for cloud service or storage use promotion via partnership driven automatic account upgrades are disclosed. In one aspect, embodiments of the present disclosure include a method, which may be implemented on a system, for receiving a device identifier of a device used to access the cloud service or storage, at a host of the cloud service or storage, and using the device identifier, by the host, to determine whether a promotion currently exists for the device and for identifying details of the promotion. One embodiment further includes, upgrading an account used to access the cloud service or storage in response to determining that the promotion exists. The use of the cloud service or storage can be promoted at the device by a physical or electronic imprint depicting the promotion available when accessed at the device | 10-03-2013 |
20130332409 | AUTOMATIC AND SEMI-AUTOMATIC TAGGING FEATURES OF WORK ITEMS IN A SHARED WORKSPACE FOR METADATA TRACKING IN A CLOUD-BASED CONTENT MANAGEMENT SYSTEM WITH SELECTIVE OR OPTIONAL USER CONTRIBUTION - Systems and methods for supporting metadata for work items stored in a web-based content management system with collaboration environment are disclosed. Users uploading work items to a folder are not required to provide metadata for the work items. Collaborators of the folder can provide metadata to work items within the folder. | 12-12-2013 |
20140082093 | BATCHING NOTIFICATIONS OF ACTIVITIES THAT OCCUR IN A WEB-BASED COLLABORATION ENVIRONMENT - Systems and methods of batched notifications of activities that occur in a web-based collaboration environment are disclosed. In one aspect, embodiments of the present disclosure include a method, which may be implemented on a system, for detecting activities occurring in an online collaboration environment, generating a notification event for one or more of the activities, and selecting one or more recipients for each notification event according to criteria determined based on a workspace in which the associated activity was performed in the online collaboration environment. The indications of each notification event are then added to one or more queues associated with the one or more recipients and, upon expiry of a queue timer, the contents of the one or more queues associated with the one or more recipients are sent to the corresponding one or more recipients as batched notifications. | 03-20-2014 |
20140101094 | ENHANCED QUICK SEARCH FEATURES, LOW-BARRIER COMMENTING/INTERACTIVE FEATURES IN A COLLABORATION PLATFORM - Embodiments of the present disclosure include systems and methods for enhanced quick search features, low-barrier comenting/interactive features in a collaboration platform, which may be a cloud-based platform. The disclosed technology enhances the user experience (both web and mobile user experience) by providing the ease with which the manner in which content and users can be discovered and browsed. Additionally, enhanced social features surrounding content is also disclosed. The disclosed technology further enhances the user experience by providing the ability to ‘like’ a file as a quick, easy way users/collaborators can note approval, attention, or preference of a file/work item. | 04-10-2014 |
20140101251 | CORPORATE USER DISCOVERY AND IDENTIFICATION OF RECOMMENDED COLLABORATORS IN A CLOUD PLATFORM - Embodiments of the present disclosure include systems and methods for user discovery (e.g., corporate user discovery) and/or identification of recommended or suggested collaborators in a collaboration platform which may be a cloud-based platform. The disclosed technology enables a user to discover a network of users that they could be collaborating with but are not. This feature, can for example, identify the relevant users or the suggested users and depict the users in the user interface. The identification and selection of the suggested users/potential collaborators can be based on some criteria (e.g., email domain, when the account was created, etc.). These criteria can be set by system default, adjusted by individual users and/or configured/set by admins if a user belongs to a corporate account/enterprise account. | 04-10-2014 |
20140101310 | SEAMLESS ACCESS, EDITING, AND CREATION OF FILES IN A WEB INTERFACE OR MOBILE INTERFACE TO A COLLABORATIVE CLOUD PLATFORM - Systems and methods for seamless access, editing, creating of files in a web or mobile interface to a collaborative cloud platform (e.g., cloud-based file sharing, collaboration and/or storage service) are disclosed herein. In one embodiment, a file accessed through the web or mobile interface is associated with an “Edit” button/action, or other similar feature. When selected, if an editor or other native application to edit or access the file is not installed, this action can automatically launch the installer and prompt the user to install the editor. If it is installed, this action can launch the native application on the user's computer. | 04-10-2014 |
20140258972 | SYSTEM AND METHOD FOR GENERATING EMBEDDABLE WIDGETS WHICH ENABLE ACCESS TO A CLOUD-BASED COLLABORATION PLATFORM - Techniques are disclosed for generating embeddable widgets capable of accessing contents in a cloud-based platform. In one embodiment, a method comprises receiving a request identifying a target content in the cloud-based platform. The method further comprises automatically generating a plurality of software codes which correspond to a software widget that enables access to the target content. According to some embodiments, the software widget is to be embedded in a software product so as to enable a user of the software product to access the target content without navigating away from the software product. Among other advantages, embodiments disclosed herein provide easy integration of centralized contents to users and third-party web-service vendors, and reduce the effort necessary for system administrators in controlling data security and tracking different activities performed to the centralized content, thereby enabling more intuitive user experience without sacrificing data security. | 09-11-2014 |
20150082195 | SIMULTANEOUS EDITING/ACCESSING OF CONTENT BY COLLABORATOR INVITATION THROUGH A WEB-BASED OR MOBILE APPLICATION TO A CLOUD-BASED COLLABORATION PLATFORM - Techniques are disclosed for a web or mobile interface enabling users and collaborators to simultaneously comment, edit, or edit content in real time or near real time managed by a cloud-based collaboration platform. In one embodiment, the data to be accessed concurrently is presented or depicted at the multiple physical devices to the collaborators for viewing and accessing the data in real time or near real time. Each of the collaborators is able to view, re-edit, or re-modify in a concurrent fashion, at the collaborator's physical device, edits or modifications made to the data in real time or near real time as a result of any of the other collaborators accessing the data at their respective physical devices. In some instances, additional collaborators are specifiable for the data created for concurrent real time access in addition to those originally associated with the folder. | 03-19-2015 |
20150082196 | SIMULTANEOUS EDITING/ACCESSING OF CONTENT BY COLLABORATOR INVITATION THROUGH A WEB-BASED OR MOBILE APPLICATION TO A CLOUD-BASED COLLABORATION PLATFORM - Techniques are disclosed for a web or mobile interface enabling users and collaborators to simultaneously comment, edit, or edit content in real time or near real time managed by a cloud-based collaboration platform. In one embodiment, the data to be accessed concurrently is presented or depicted at the multiple physical devices to the collaborators for viewing and accessing the data in real time or near real time. Each of the collaborators is able to view, re-edit, or re-modify in a concurrent fashion, at the collaborator's physical device, edits or modifications made to the data in real time or near real time as a result of any of the other collaborators accessing the data at their respective physical devices. In some instances, additional collaborators are specifiable for the data created for concurrent real time access in addition to those originally associated with the folder. | 03-19-2015 |
Patent application number | Description | Published |
20080312600 | FLEXIBLE MEDICAL DEVICE CONDUIT - A flexible medical device conduit includes an elongated framework formed from a flexible material (e.g., Nitinol) with a body portion, sharp head, distal end and proximal end. The flexible medical device conduit also includes a flexible tube at least partially jacketing the elongated framework between the distal end and the proximal end. Moreover, the sharp head is disposed at the distal end and is configured for subcutaneous skin insertion and the elongated framework and flexible tube define at least one conduit between the elongated framework and the flexible tube, the conduit having an opening at the distal end. | 12-18-2008 |
20090247982 | Medical Device Mechanical Pump - A medical device pump with a housing with a compartment for removably receiving a cartridge containing a therapeutic agent, a conduit configured to operatively provide a fluid flow path for therapeutic agent to exit from the cartridge, a user activated delivery button, a trigger mechanism, and a mechanical pump mechanism. The trigger mechanism, user activated delivery button and mechanical pump mechanism of the medical device pump are configured such that the trigger mechanism is activated by a user fully activating the user activated delivery button. Moreover, such full activation generates mechanical power employed by, and sufficient for, the mechanical pump mechanism to pump a predetermined volume of therapeutic agent from the cartridge and through the fluid flow path. | 10-01-2009 |
20100016700 | ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS - Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods. | 01-21-2010 |
20100198033 | FLEXIBLE INDWELLING BIOSENSOR, FLEXIBLE INDWELLING BIOSENSOR INSERTION DEVICE, AND RELATED METHODS - A flexible indwelling biosensor includes an elongated framework formed from a flexible material (e.g., a Nitinol strip) with a body portion, a sharp head, a distal end, and a proximal end. The flexible indwelling sensor also includes a biosensor (such as an interstitial fluid glucose sensor) integrated with the elongated framework with the biosensor having a sensing element disposed over (for example, on or suspended over) at least one of the body portion or sharp head of the elongated framework. Moreover, the sharp head is disposed at the distal end of the elongated framework and the sharp head and at least the sensing element of the biosensor are configured for insertion into a target site (for example, a subcutaneous target site). | 08-05-2010 |
20100300897 | FLEXIBLE INDWELLING ELECTROCHEMICAL-BASED BIOSENSOR AND RELATED METHODS - A flexible indwelling electrochemical-based biosensor includes an elongated framework and an integrated electrochemical-based biosensor. The elongated framework is formed of an electrically conductive flexible material (e.g., a Nitinol) with a body portion, a sharp head, a distal end and a proximal end. The integrated electrochemical-based biosensor (such as an electrochemical-based glucose sensor) is integrated with the elongated framework in that the biosensor has a sensing element that is disposed over the body portion or sharp head of the elongated framework and a portion of the elongated framework is configured as an electrode component that electrically cooperates with the sensing element. The electrode component can, for example, be configured to electrically cooperate as a working electrode, counter electrode, reference electrode or combined reference/counter electrode of the sensing element. Moreover, the sharp head is disposed at the distal end of the elongated framework and the sharp head, the electrode component and at least the sensing element of the biosensor are configured for insertion into a target site (for example, a subcutaneous target site). | 12-02-2010 |
20110313349 | MEDICAL MODULE FOR DRUG DELIVERY PEN - Various embodiments of a medical module are provided which includes a primary module housing, a secondary module housing, a dosage sensor, a power source, and a microcontroller. The module is configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen so that the module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. | 12-22-2011 |
20110313350 | DRUG DELIVERY SYSTEM - Various embodiments of a “smart” drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. | 12-22-2011 |
20120004637 | DRUG DELIVERY MANAGEMENT SYSTEMS AND METHODS - Various embodiments of a “smart” drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen in conjunction with a data management unit(s) DMU. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reuse of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. Methods of using the drug delivery system are also described. | 01-05-2012 |
Patent application number | Description | Published |
20100055145 | STENT COATINGS FOR REDUCING LATE STENT THROMBOSIS - Devices and methods relate to drug-eluting stents and coatings, thereof, for reduced late stent thrombosis are described. | 03-04-2010 |
20100094408 | Drug-Delivery Endovascular Stent and Method for Treating Restenosis - An intravascular stent and method for inhibiting restenosis, following vascular injury, is disclosed. The stent has an expandable, linked-filament body and a drug-release coating formed on the stent-body filaments, for contacting the vessel injury site when the stent is placed in-situ in an expanded condition. The coating releases, for a period of at least 4 weeks, a restenosis-inhibiting amount of the macrocyclic triene immunosuppressive compound everolimus. The stent, when used to treat a vascular injury, gives good protection against clinical restenosis, even when the extent of vascular injury involves vessel overstretching by more than 30% diameter. Also disclosed is a stent having a drug-release coating composed of (i) 10 and 60 weight percent poly-dl-lactide polymer substrate and (ii) 40-90 weight percent of an anti-restenosis compound, and a polymer undercoat having a thickness of between 1-5 microns. | 04-15-2010 |
20110123704 | DRUG-DELIVERY ENDOVASCULAR STENT AND METHOD FOR TREATING RESTENOSIS - A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating. | 05-26-2011 |
20120029626 | DRUG DELIVERY ENDOVASCULAR STENT AND METHOD OF USE - A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments where at least one surface of the filaments has a roughened or abraded surface. The stent may include a therapeutic agent on the abraded surface. | 02-02-2012 |
20120290076 | DRUG-DELIVERY ENDOVASCULAR STENT AND METHOD FOR TREATING RESTENOSIS - A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating. | 11-15-2012 |
20120330406 | DRUG DELIVERY ENDOVASCULAR STENT AND METHOD OF USE - An improvement in drug-eluting stents, and method of their making, are disclosed. The surface of a metal stent is roughened to have a surface roughness of at least about 20 μin (0.5 μm) and a surface roughness range of between about 300-700 μin (7.5-17.5 μm). The roughened stent surface is covered with a polymer-free coating of a limus drug, to a coating thickness greater than the range of surface roughness of the roughened stent surface. | 12-27-2012 |
20130006350 | DRUG-DELIVERY ENDOVASCULAR STENT AND METHOD FOR TREATING RESTENOSIS - An intravascular stent and method for inhibiting restenosis, following vascular injury, is disclosed. The stent has an expandable, linked-filament body and a drug-release coating formed on the stent-body filaments, for contacting the vessel injury site when the stent is placed in-situ in an expanded condition. The coating releases, for a period of at least 4 weeks, a restenosis-inhibiting amount of the macrocyclic triene immunosuppressive compound everolimus. The stent, when used to treat a vascular injury, gives good protection against clinical restenosis, even when the extent of vascular injury involves vessel overstretching by more than 30% diameter. Also disclosed is a stent having a drug-release coating composed of (i) 10 and 60 weight percent poly-dl-lactide polymer substrate and (ii) 40-90 weight percent of an anti-restenosis compound, and a polymer undercoat having a thickness of between 1-5 microns. | 01-03-2013 |
20130035754 | DRUG-DELIVERY ENDOVASCULAR STENT AND METHOD OF FORMING THE SAME - An intravascular stent and method for inhibiting restenosis, following vascular injury, is disclosed. The stent has an expandable, linked-filament body and a drug-release coating formed on the stent-body filaments, for contacting the vessel injury site when the stent is placed in-situ in an expanded condition. The coating releases, for a period of at least 4 weeks, a restenosis-inhibiting amount of a monocyclic triene immunosuppressive compound having an alkyl group substituent at carbon position 40 in the compound. The stent, when used to treat a vascular injury, gives good protection against clinical restenosis, even when the extent of vascular injury involves vessel overstretching by more than 30% diameter. Also disclosed is a stent having a drug-release coating composed of (i) 10 and 60 weight percent poly-dl-Iactide polymer substrate and (ii) 40-90 weight percent of an anti-restenosis compound, and a polymer undercoat having a thickness of between 1-5 microns. | 02-07-2013 |
20140200654 | DRUG-DELIVERY ENDOVASCULAR STENT AND METHOD OF FORMING THE SAME - An intravascular stent and method for inhibiting restenosis, following vascular injury, is disclosed. The stent has an expandable, linked-filament body and a drug-release coating formed on the stent-body filaments, for contacting the vessel injury site when the stent is placed in-situ in an expanded condition. The coating releases, for a period of at least 4 weeks, a restenosis-inhibiting amount of a monocyclic triene immunosuppressive compound having an alkyl group substituent at carbon position 40 in the compound. The stent, when used to treat a vascular injury, gives good protection against clinical restenosis, even when the extent of vascular injury involves vessel overstretching by more than 30% diameter. Also disclosed is a stent having a drug-release coating composed of (i) 10 and 60 weight percent poly-dl-lactide polymer substrate and (ii) 40-90 weight percent of an anti-restenosis compound, and a polymer undercoat having a thickness of between 1-5 microns. | 07-17-2014 |
Patent application number | Description | Published |
20090299447 | DEPLOYABLE EPICARDIAL ELECTRODE AND SENSOR ARRAY - Minimally invasive deployable epicardial array devices are provided. The devices include deployable platform comprising two or more effectors, such as sensors and actuators, where the devices are configured to be deployed at an epicardial location via a minimally invasive, e.g., sub-xiphoid approach. In embodiments of the present invention, at least one area of the electrode patch is an electrical control area that comprises a series of effectors, e.g., sensors and/or electrodes. Other embodiments provide localized physical constraint and dynamic mechanical stimulation of the heart to effectuate physical and biological responses. Still other embodiments provide both of these functions. Also provided are methods of using the devices, as well as systems and kits that include the devices. | 12-03-2009 |
20100185055 | INGESTIBLE EVENT MARKER SYSTEMS - Ingestible event marker systems that include an ingestible event marker (i.e., an IEM) and a personal signal receiver are provided. Embodiments of the IEM include an identifier, which may or may not be present in a physiologically acceptable carrier. The identifier is characterized by being activated upon contact with a target internal physiological site of a body, such as digestive tract internal target site. The personal signal receiver is configured to be associated with a physiological location, e.g., inside of or on the body, and to receive a signal the IEM. During use, the IEM broadcasts a signal which is received by the personal signal receiver. | 07-22-2010 |
20100228312 | Implantable Cardiac Motion Powered Piezoelectric Energy Source - Implantable cardiac motion powered piezoelectric energy sources are provided. Aspects of the subject implantable energy sources they include a piezoelectric transducer that converts cardiac mechanical energy to electrical energy. The subject energy sources find use in a variety of applications, including providing power to a wide range of implantable devices. | 09-09-2010 |
20100280366 | CONTINUOUS FIELD TOMOGRAPHY SYSTEMS AND METHODS OF USING THE SAME - Continuous field tomography systems are provided. Aspects of systems include a data aggregating module configured to receive both continuous field tomography data and non-continuous field physiological data and produce an aggregated data product from these disparate types of data. Also provided are methods of using systems of the invention in a variety of different applications, including diagnostic and therapeutic applications. The systems and methods of the invention find use in a variety of different applications, such as cardiac related applications. | 11-04-2010 |
20100312188 | Body-Associated Receiver and Method - Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems. | 12-09-2010 |
20110009715 | INGESTIBLE EVENT MARKER DATA FRAMEWORK - The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event. | 01-13-2011 |
20110040203 | EVALUATION OF GASTROINTESTINAL FUNCTION USING PORTABLE ELECTROVISCEROGRAPHY SYSTEMS AND METHODS OF USING THE SAME - Portable electroviscerography systems are provided. Aspects of the systems include a body-associated receiver and an ingestible identifier unit, both of which are configured to detect visceral electrical signals. The system communicates with an extra-corporeal data processor configured to receive data from the body-associated receiver and generate and electroviscerogram from the received data. Also provided are methods of producing electroviscerograms using systems of the present invention. | 02-17-2011 |
20110196454 | SENSING SYSTEM, DEVICE, AND METHOD FOR THERAPY MODULATION - Sensing system, device, and method for therapy modulation are provided. Various aspects include a receive module and a therapy-related action module. The receive module may receive a therapy parameter of an individual. The therapy-related action module may effectuate, based on the therapy parameter, a therapy-related action associated with a nervous system of the individual. | 08-11-2011 |
20110212782 | Method and System for Incorporating Physiologic Data in a Gaming Environment - The present invention provides a receiving device and method for use with gaming pursuits, including, in one aspect, a personal signal receiver to communicate physiologic data, a hub to receive the physiologic data, and a gaming module to receive, directly or indirectly, the physiologic data from the hub. | 09-01-2011 |
20110270052 | Ingestion-Related Biofeedback and Personalized Medical Therapy Method and System - Methods, devices and systems for acquiring information useful to support a patient in implementing and adhering to a medically prescribed therapy plan are provided. The therapy may incorporate biofeedback methods and/or personalized therapy aspects. A method includes steps of receiving, by a receiving device, biometric information associated with an ingestible event marker; analyzing, by a computing device having a microprocessor configured to perform a biometric information analysis, the biometric information; and determining a therapeutic recommendation at least partly on the basis of the analysis and/or integrating biofeedback techniques into patient therapy or activity. A system includes a biometric information module to receive biometric information associated with an ingestible event marker; an analysis module to analyze the biometric information; and a determination module to optionally determine and communicate a therapeutic recommendation at least partly on the basis of the analysis. | 11-03-2011 |
20120004527 | Communication System Using an Implantable Device - The system of the present invention includes an implantable device that can detect high and low frequency current signature. The implantable device can communicate with a communication device that includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, the communication device is activated. | 01-05-2012 |
20120016211 | Evaluation of Gastrointestinal Function Using Portable Electroviscerography Systems and Methods of Using the Same - Portable electroviscerography systems are provided. Aspects of the systems include a body-associated receiver and an ingestible identifier unit, both of which are configured to detect visceral electrical signals. The system communicates with an extra-corporeal data processor configured to receive data from the body-associated receiver and generate and electroviscerogram from the received data. Also provided are methods of producing electroviscerograms using systems of the present invention. | 01-19-2012 |
20120059257 | Ingestible Event Markers Comprising an Ingestible Component - Ingestible event markers comprising an identifier and an ingestible component are provided. The ingestible component may vary, where ingestible components of interest include osmotic ingestible components, liquid capsules, tablets, multi-layered ingestible component and multi-compartment ingestible components. In some instances, the identifier is mechanically stably associated with the ingestible component. Also provided are systems that include the ingestible event markers, as well as methods of using the ingestible event markers. | 03-08-2012 |
20120101430 | Body-Associated Receiver and Method - Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems. | 04-26-2012 |
20130096501 | System and Method for Patient Access Port Reporting - A method is disclosed for detecting, by a sensing and data acquisition circuit module, at least one parameter associated with an access port. The method includes wiping at least a portion of an access port, allowing the access port to dry for a predetermined amount of time, accessing the access port with an access device, such as a syringe, and detecting at least one parameter associated with the access port by the sensor and acquisition module. An access port is disclosed that includes a sensor and a data acquisition module for sensing, recording, and providing an alert associated with the detection of the at least one parameter associated with the access port. | 04-18-2013 |
20130172690 | APPARATUS, SYSTEM AND METHOD FOR DETECTION AND DELIVERY OF A MEDICINAL DOSE - An apparatus is disclosed as part of a system for tracking and confirming delivery of a medicinal dose to a user. The apparatus includes a detector. The detector is secured to and communicatively coupled to the user and is capable of detecting a current flow through the user's body. The current flow is produced when the user makes contact with the apparatus. The apparatus includes at least two contact areas connected to a power source where a circuit and, hence, a current path is completed through the user's body as the user makes contact with the apparatus. The current flow is detected by the detector, which is coupled to the user. Also disclosed is an apparatus for tracking and confirming delivery of a medicinal dose to a user where the apparatus includes an acoustic detector. Upon loading the dose into a chamber an acoustic vibration is generated. The vibration is detected and correlated with a current flow that is produced when the user makes contact with the apparatus. The combined event of vibration detection and current flow detection confirms that the dose is loaded and the user is in contact with the apparatus and ready to receive the dose. | 07-04-2013 |
20140009262 | PERSONAL AUTHENTICATION APPARATUS SYSTEM AND METHOD - A target authentication device includes an electrode to detect an electrical signal associated with a user of the device. The electrical signal represents an authentication code for the device. An authentication receiver module is coupled to the electrode. The module receives the electrical signal from the electrode and determines whether the electrical signal matches a predetermined criterion to authenticate the identity of the user based on the electrical signal. An authentication module is also disclosed. The authentication module includes one electrode to couple an electrical signal associated with a user to a user of a target authentication device, the electrical signal represents an authentication code for the device. An authentication transmission module is coupled to the electrode. The authentication transmission module transmits the electrical signal from the electrode. A method of authenticating the identity of a user of a target authentication device also is disclosed. | 01-09-2014 |
20140236077 | Body-Associated Receiver and Method - Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems. | 08-21-2014 |
20150051465 | Ingestible Event Marker Systems - Ingestible event marker systems that include an ingestible event marker (i.e., an IEM) and a personal signal receiver are provided. Embodiments of the IEM include an identifier, which may or may not be present in a physiologically acceptable carrier. The identifier is characterized by being activated upon contact with a target internal physiological site of a body, such as digestive tract internal target site. The personal signal receiver is configured to be associated with a physiological location, e.g., inside of or on the body, and to receive a signal the IEM. During use, the IEM broadcasts a signal which is received by the personal signal receiver. | 02-19-2015 |
20150080677 | Communication System Using an Implantable Device - The system of the present invention includes an implantable device that can detect high and low frequency current signature. The implantable device can communicate with a communication device that includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, the communication device is activated. | 03-19-2015 |
20150127737 | SOCIAL MEDIA NETWORKING BASED ON PHYSIOLOGIC INFORMATION - A method comprising receiving physiologic information at a social-networking system from a body-associated personal communicator is disclosed. A social-networking system configured to receive physiological information from a body-associated personal communicator and a body-associated personal communicator configured to receive physiologic information and communicate the physiologic information to a social-networking system also are disclosed. | 05-07-2015 |
Patent application number | Description | Published |
20080208068 | DYNAMIC POSITIONAL INFORMATION CONSTRAINED HEART MODEL - Methods and systems for producing a computational model of the heart which is patient-specific are provided. Embodiments of the methods and systems include providing a computational model of a heart, obtaining dynamic positional information data from a patient and modifying the heart model with the dynamic positional information data to produce a patient-specific heart model. The invention finds use in a variety of different applications, including but not limited to diagnosis and treatment of heart conditions. | 08-28-2008 |
20080242976 | Electric field tomography - Methods for evaluating motion of a tissue, such as of a cardiac location, e.g., heart wall, via continuous field tomography are provided. In the subject methods, a continuous field (e.g., an electrical, mechanical, electromechanical, or other field) sensing element is stably associated with the tissue location. A property of the applied continuous field is detected with the sensing element to evaluate movement of the tissue location. Also provided are systems, devices and related compositions for practicing the subject methods. The subject methods and devices find use in a variety of different applications, including cardiac resynchronization therapy. | 10-02-2008 |
20080255629 | Cardiac Motion Characterization by Strain Measurement - Methods for evaluating motion of a cardiac tissue location, e.g., heart wall, are provided. In the subject methods, timing of a signal obtain from a strain gauge stably associated with the tissue location of interest is employed to evaluate movement of the cardiac tissue location. Also provided are systems, devices and related compositions for practicing the subject methods. The subject methods and devices find use in a variety of different applications, including cardiac resynchronization therapy. | 10-16-2008 |
20080255647 | Implantable Addressable Segmented Electrodes - Implantable addressable segmented electrode devices, as well as methods for making and using the same, are provided. The subject devices include segmented electrode structures made up of an integrated circuit electrically coupled to two or more electrodes, where each electrode can be individually activated. Also provided are implantable devices and systems, as well as kits containing such devices and systems or components thereof, which include the segmented electrode structures. | 10-16-2008 |
20080294218 | Automated Optimization of Multi-Electrode Pacing for Cardiac Resynchronization - One embodiment of the present invention provides a system for automatically optimizing CRT procedures using a multi-electrode pacing lead. During operation, the system performs a first set of iterations to select one or more satellites on one or more pacing leads inserted in a patient. A pacing lead includes a plurality of pacing satellites, and a pacing satellite includes a plurality of electrodes that can be individually addressed and used for transmitting or detecting electric signals. The system then performs a second set of iterations to select one or more electrodes on the selected satellites. The system further performs a third set of iterations to select one or more timing configurations for pacing signals transmitted through one or more of the selected electrodes. | 11-27-2008 |
20080306394 | Measuring Conduction Velocity Using One or More Satellite Devices - A method for measuring the conduction velocity of a depolarization wave in a tissue employs a first satellite located within the tissue and a second that satellite is located within the tissue a distance away from the first satellite, e.g., by using the time of depolarization wave as reported from each satellite and the distance to determine velocity of the wave. Also provided are systems and kits that find use in accordance with the invention. | 12-11-2008 |
20090076338 | PATIENT CUSTOMIZED THERAPEUTIC REGIMENS - Methods, systems and compositions that allow for treating a patient according to a patient customized therapeutic regimen are provided. Embodiments of the invention include obtaining dosage administration information from a patient and using the same to tailor a therapeutic regimen for the patient. Embodiments of the invention further include preparing and forwarding to the patient physical pharmaceutical dosages based on the customized therapeutic regimen. | 03-19-2009 |
20110172521 | Implantable Doppler Tomography System - The inventive implantable Doppler tomography system allows, for the first time, the use of Doppler shift for purposes of tracking cardiac wall motion. The present inventive Doppler tomography system methods and devices provide a critical new tool in the physician's armamentarium which provides accurate, real time monitoring of the mechanical performance of the heart. | 07-14-2011 |
20130046356 | HIGH PHRENIC, LOW CAPTURE THRESHOLD PACING DEVICES AND METHODS - Methods of highly selective cardiac tissue stimulation and devices for practicing the same, e.g., implantable segmented electrode devices, are provided. The methods and devices provide a previously unavailable high phrenic nerve capture voltage paired with a low pacing capture voltage threshold. The subject methods and devices provide a number of benefits. For example, patients who previously would have been required to have their resynchronization device turned off due to phrenic nerve capture will now be able to reap the benefits of resynchronization therapy. | 02-21-2013 |
20150193593 | PATIENT CUSTOMIZED THERAPEUTIC REGIMENS - Methods, systems and compositions that allow for treating a patient according to a patient customized therapeutic regimen are provided. Embodiments of the invention include obtaining dosage administration information from a patient and using the same to tailor a therapeutic regimen for the patient. Embodiments of the invention further include preparing and forwarding to the patient physical pharmaceutical dosages based on the customized therapeutic regimen. | 07-09-2015 |
Patent application number | Description | Published |
20120110062 | DATA DELIVERY - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for support dependent post delivery. In one aspect, a method included generating transmission data for a web page served by a first server and rendered on the client device, the first sever belonging to a first domain; determining if the client device supports cross origin resource sharing; in response to a determination that the client device does not support cross origin resource sharing: defining an iFrame for the web page, the iFrame belonging to a second domain of a receiving server, and having a name value derived from the transmission data, receiving iFrame instructions from the receiving server and executing the iFrame instructions in the iFrame, the iFrame instruction causing the client device to: generate an HTTP POST request to the receiving server from the iFrame name value, the first HTTP POST request including the transmission data. | 05-03-2012 |
20130204932 | DATA DELIVERY - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for support dependent post delivery. In one aspect, a method included generating transmission data for a web page served by a first server and rendered on the client device, the first sever belonging to a first domain; determining if the client device supports cross origin resource sharing; in response to a determination that the client device does not support cross origin resource sharing: defining an iFrame for the web page, the iFrame belonging to a second domain of a receiving server, and having a name value derived from the transmission data, receiving iFrame instructions from the receiving server and executing the iFrame instructions in the iFrame, the iFrame instruction causing the client device to: generate an HTTP POST request to the receiving server from the iFrame name value, the first HTTP POST request including the transmission data. | 08-08-2013 |
20140282025 | MATCHING WEBSITE VISITS WITH CONTENT SELECTION PARAMETERS - Methods and systems for matching a plurality of visits to a website with a plurality of content selection parameters including aggregating a number of visits to the website, determining whether the website includes an identifier, based on the determination, retrieving information associated with the identifier, wherein the information comprises the plurality of content selection parameters, and matching the plurality of content selection parameters with the plurality of visits to the website to create a report. | 09-18-2014 |
20150372888 | DATA DELIVERY - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for support dependent post delivery. In one aspect, a method included generating transmission data for a web page served by a first server and rendered on the client device, the first sever belonging to a first domain; determining if the client device supports cross origin resource sharing; in response to a determination that the client device does not support cross origin resource sharing: defining an iFrame for the web page, the iFrame belonging to a second domain of a receiving server, and having a name value derived from the transmission data, receiving iFrame instructions from the receiving server and executing the iFrame instructions in the iFrame, the iFrame instruction causing the client device to: generate an HTTP POST request to the receiving server from the iFrame name value, the first HTTP POST request including the transmission data. | 12-24-2015 |
Patent application number | Description | Published |
20130216010 | MONOBIT RECEIVER SPURIOUS HARMONICS CONTROL METHOD AND SYSTEM - A method for minimizing unwanted signal harmonics from at least one signal in a channel received through a monobit receiver, comprising: conditioning ( | 08-22-2013 |
20130329771 | WIDEBAND LOW LATENCY REPEATER AND METHODS - A signal repeater ( | 12-12-2013 |
20140105256 | Band Stitching Electronic Circuits and Techniques - An electronic circuit combines two or more individual wideband RF receivers or transceiver band circuits to produce a usable instantaneous bandwidth that is wider than the bandwidth of the individual band circuits. The electronic circuit overcomes the difficulties of combining bands to provide low signal distortion across the band edges and throughout the combined instantaneous bandwidth of the two or more individual band circuits. This electronic circuit utilizes an amplitude, time delay, and phase adjustment procedure that uses associated adjustable circuitry to eliminate misalignments between the two or more individual band circuits. | 04-17-2014 |
20140139374 | KALMAN FILTERING WITH INDIRECT NOISE MEASUREMENTS - Accurate remote tracking of fixed objects from a moving platform requires overcoming platform noise. Such tracking becomes difficult when the only inertial reference (such as a central aircraft inertial navigation system) is remote from the sensor, which experiences non-measured angular movements due to airframe vibrations and flexing. In such a scenario, Kalman filtering cannot converge on a true value because all noise sources are not known. Current naïve approaches arbitrarily boost noise with fixed additive or multiplicative factors. However, such approaches slow filter response and; thus, often fail to give timely results. Embodiments of the present disclosure derive inertial reference parameters to quantify noise of the sensor that is remote from the inertial reference. Advantageously, disclosed embodiments enable use of remote sensors with an existing inertial reference, rather than consolidating sensors and the inertial reference at a single location or providing inertial references at each sensor. | 05-22-2014 |
20140278214 | FREQUENCY DIFFERENCE OF ARRIVAL (FDOA) FOR GEOLOCATION - A method for determining a FDOA of a pulsed waveform received by two sensors includes obtaining a respective plurality of in-phase and quadrature-phase (IQ) samples indicative of a pulse envelope of the received pulsed waveform. The method includes determining a TDOA responsive to a leading edge of a pulse of the pulsed waveform and obtaining a first cross correlation of IQ samples at a delay (d | 09-18-2014 |
20140281779 | ITERATIVE KALMAN FILTERING - Several types of noise limit the performance of remote sensing systems, e.g., systems that determine the location, color, or shape of remote objects. When noise detected by sensors of the remote sensing systems is known and well estimated, a Kalman filter can converge on an accurate value without noise. However, non-Gaussian noise bursts can cause the Kalman filter to diverge from an accurate value. Current approaches arbitrarily boost noise with fixed additive or multiplicative factors. Such approaches slow filter response and; thus, often fail to give timely results. Such noise boosts prevent divergence due to badly corrupted measurements. Disclosed embodiments eliminate a subset of noise measurements having the largest errors from a data set of noise measurements and process the remaining data through the Kalman filter. Advantageously, disclosed embodiments enable a Kalman filter to converge on an accurate value without the introduction of noise boost estimates, which adds processing time. | 09-18-2014 |